Showing results (781-790 of 816) with videos related to
Sort By:
Pageof 82
Haematologica|August 18, 2018
Feasibility and efficacy of addition of individualized-dose lenalidomide to chlorambucil and rituximab as first-line treatment in elderly and FCR-unfit patients with advanced chronic lymphocytic leukemiaArnon P Kater, Marinus H J van Oers, Yvette van Norden, et al.Cells|September 14, 2024
An Abscopal Effect on Lung Metastases in Canine Mammary Cancer Patients Induced by Neoadjuvant Intratumoral Immunotherapy with Cowpea Mosaic Virus Nanoparticles and Anti-Canine PD-1Petra Sergent, Juan Carlos Pinto-Cárdenas, Adhara Jaciel Arreguin Carrillo, et al.Haematologica|March 1, 2013
Age and organ damage correlate with poor survival in myeloma patients: meta-analysis of 1435 individual patient data from 4 randomized trialsSara Bringhen, Maria Victoria Mateos, Sonja Zweegman, et al.Geohealth|April 22, 2026
All Hazards Great and Small: Applying Disaster Risk Reduction to Environmental Justice Communities in South CarolinaDaniel J Kilpatrick, Keisha D Long, Omar Muhammad, et al.Communications Earth & Environment|June 9, 2025
Seasonal vertical migration of large polar copepods reinterpreted as a dispersal mechanism throughout the water columnKatrin Schmidt, Barbara Niehoff, Astrid Cornils, et al.Journal of Stroke|October 14, 2025
Decision-Making for Endovascular Thrombectomy in Patients With Large Vessel Occlusions and Mild Neurological Deficit: A Consensus StatementSalome L Bosshart, Manon Kappelhof, Alexander Stebner, et al.Experimental Hematology|August 12, 2020
Proteomic markers with prognostic impact on outcome of chronic lymphocytic leukemia patients under chemo-immunotherapy: results from the HOVON 109 studyFatemeh Saberi Hosnijeh, Lina van der Straten, Arnon P Kater, et al.American Journal of Hematology|November 26, 2013
Bortezomib, melphalan, prednisone (VMP) versus melphalan, prednisone, thalidomide (MPT) in elderly newly diagnosed multiple myeloma patients: A retrospective case-matched studyFortunato Morabito, Sara Bringhen, Alessandra Larocca, et al.British Journal of Haematology|October 11, 2011
Platelet doubling after the first azacitidine cycle is a promising predictor for response in myelodysplastic syndromes (MDS), chronic myelomonocytic leukaemia (CMML) and acute myeloid leukaemia (AML) patients in the Dutch azacitidine compassionate named patient programmeLieke H van der Helm, Canan Alhan, Pierre W Wijermans, et al.Insects|June 26, 2024
Allele Frequencies of Genetic Variants Associated with Varroa Drone Brood Resistance (DBR) in Apis mellifera Subspecies across the European ContinentRegis Lefebre, Lina De Smet, Anja Tehel, et al.Pageof 82